氨甲环酸对创伤性脑损伤患者疗效的系统评价与Meta分析
该系统评价与Meta分析纳入5项随机对照试验共917例创伤性脑损伤患者,评估氨甲环酸的安全性与有效性。汇总结果显示氨甲环酸显著降低血肿扩大率与总血肿增长量,对手术率、死亡率及神经功能结局未显示显著差异,血栓事件发生率相似;敏感性分析排除一项低质量研究后,死亡率与神经功能结局差异变得显著。作者结论认为氨甲环酸可降低血肿扩大风险、降低死亡率并改善神经功能结局,且不增加血栓事件,早期治疗更有效。
要点
- 氨甲环酸显著降低创伤性脑损伤患者的血肿扩大率与总血肿增长量。
- 汇总分析中手术率、死亡率及神经功能结局组间无显著差异,血栓事件发生率相似。
- 敏感性分析排除一项低质量研究后,氨甲环酸对死亡率与神经功能结局的影响变得显著。
核心结论
- 氨甲环酸通过降低死亡率并改善有利神经功能结局,显著降低创伤性脑损伤患者血肿扩大风险,且不影响血栓事件发生率。
- 早期氨甲环酸治疗在减少血肿方面更有效。
研究设计与样本
- 系统评价与Meta分析,2018年7月检索PubMed、Embase和Cochrane Library数据库,仅纳入随机对照试验。
- 从426项研究中纳入5项随机对照试验,共917例创伤性脑损伤患者。
主要发现
- 血肿扩大方面,汇总结果显示氨甲环酸显著降低创伤性脑损伤患者的出血增长率与总出血增长量。
- 临床结局方面,手术率、死亡率与神经功能结局的汇总结果组间无显著差异,血栓事件发生率相似。
- 敏感性分析排除一项低质量研究后,氨甲环酸对死亡率与神经功能结局的影响变得显著。
- 确认氨甲环酸治疗越早实施,血肿体积越小。
临床怎么用
- 原文未据此给出推荐。
局限性
- 敏感性分析因一项研究质量低而将其排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Tranexamic acid (TXA) reduces hemorrhage volume and consequently the need for operative intervention. However, its effectiveness and safety in patients with traumatic brain injury (TBI) is unclear. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of TXA in patients with TBI. METHODS: In July 2018, a systematic search for studies including patients with TBI treated with TXA was conducted using PubMed, Embase, and the Cochrane Library databases. Only related randomized controlled trials were included. Main outcomes included hematoma expansion, surgery rate, death rate, neurologic outcome, and any thrombosis events. RESULTS: Of the identified 426 studies, 5 randomized controlled trials involving 917 patients met our inclusion criteria. For hematoma expansion, pooled results showed that TXA significantly decreased hemorrhage growth rate and total hemorrhage growth in patients with TBI. Regarding clinical outcomes, pooled results of surgery, mortality, and neurologic outcome showed no significant difference between the groups, and rate of thrombosis events was similar. Following sensitivity analysis, one study was excluded due to low quality. Then, results of TXA effect on mortality and neurologic outcomes became significant. We confirm that the earlier the TXA treatment is performed, the smaller the size of hematoma will be. CONCLUSIONS: TXA demonstrates significant effect in reducing the risk of hematoma expansion by lowering the mortality rate and improving favorable neurologic outcomes in patients with TBI while not affecting thrombosis event rates. In addition, early TXA treatment is more effective in decreasing hematomas.
引用
- Weng S, Wang W, Wei Q, et al. Effect of Tranexamic Acid in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis. World Neurosurg. 2018. PMID: 30529516. doi:10.1016/j.wneu.2018.11.214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。